COc1ccc(CCn2c(=O)c3cccnc3n(Cc3ccc([N+](=O)[O-])cc3)c2=O)cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?